A global perspective on FOXO1 in lipid metabolism and lipid-related diseases
- PMID: 28392404
- DOI: 10.1016/j.plipres.2017.04.002
A global perspective on FOXO1 in lipid metabolism and lipid-related diseases
Abstract
Lipid metabolism is a complex physiological process that is involved in nutrient adjustment, hormone regulation, and homeostasis. An unhealthy lifestyle and chronic nutrient overload can cause lipid metabolism disorders, which may lead to serious lipid-related diseases, including obesity, non-alcoholic fatty liver disease (NAFLD), and type 2 diabetes mellitus (T2DM). Therefore, tools for preventing dysfunctional lipid metabolism are urgently needed. The transcription factor forkhead box protein O1 (FOXO1) is involved in lipid metabolism and plays a critical role in the development of lipid-related diseases. In this review, we provide a global perspective on the role of FOXO1 in lipid metabolism and lipid-related diseases. The information included here may be useful for the design of future studies and advancing investigations of FOXO1 as a therapeutic target.
Keywords: Forkhead box protein O1; Lipid metabolism; Lipid-related diseases.
Copyright © 2017. Published by Elsevier Ltd.
Similar articles
-
Phytochemicals targeting NAFLD through modulating the dual function of forkhead box O1 (FOXO1) transcription factor signaling pathways.Naunyn Schmiedebergs Arch Pharmacol. 2022 Jul;395(7):741-755. doi: 10.1007/s00210-022-02234-2. Epub 2022 Mar 31. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 35357518 Review.
-
A Review of FoxO1-Regulated Metabolic Diseases and Related Drug Discoveries.Cells. 2020 Jan 10;9(1):184. doi: 10.3390/cells9010184. Cells. 2020. PMID: 31936903 Free PMC article. Review.
-
Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).Eur J Pharmacol. 2016 Oct 5;788:306-314. doi: 10.1016/j.ejphar.2016.06.043. Epub 2016 Jun 24. Eur J Pharmacol. 2016. PMID: 27349145
-
Forkhead Box Protein O1: Functional Diversity and Post-Translational Modification, a New Therapeutic Target?Drug Des Devel Ther. 2021 May 3;15:1851-1860. doi: 10.2147/DDDT.S305016. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 33976536 Free PMC article. Review.
-
Molecular Mechanism of Betaine on Hepatic Lipid Metabolism: Inhibition of Forkhead Box O1 (FoxO1) Binding to Peroxisome Proliferator-Activated Receptor Gamma (PPARγ).J Agric Food Chem. 2016 Sep 14;64(36):6819-25. doi: 10.1021/acs.jafc.6b02644. Epub 2016 Sep 1. J Agric Food Chem. 2016. PMID: 27546313
Cited by
-
Chemerin affects blood lipid profile of high-fat diet male mice in sedentary and exercise states via glucose and lipid metabolism enzymes.Endocr Connect. 2024 Feb 29;13(4):e230484. doi: 10.1530/EC-23-0484. Print 2024 Apr 1. Endocr Connect. 2024. PMID: 38323605 Free PMC article.
-
Transcription Factor EB: A Promising Therapeutic Target for Ischemic Stroke.Curr Neuropharmacol. 2024;22(2):170-190. doi: 10.2174/1570159X21666230724095558. Curr Neuropharmacol. 2024. PMID: 37491856 Free PMC article.
-
Puerarin as a multi-targeted modulator of lipid metabolism: molecular mechanisms, therapeutic potential and prospects for nutritional translation.Front Nutr. 2025 Jul 18;12:1598897. doi: 10.3389/fnut.2025.1598897. eCollection 2025. Front Nutr. 2025. PMID: 40756564 Free PMC article. Review.
-
Schwann Cells Accelerate Osteogenesis via the Mif/CD74/FOXO1 Signaling Pathway In Vitro.Stem Cells Int. 2022 Jan 13;2022:4363632. doi: 10.1155/2022/4363632. eCollection 2022. Stem Cells Int. 2022. PMID: 35069747 Free PMC article.
-
The role and implication of autophagy in cholangiocarcinoma.Cell Death Discov. 2023 Sep 4;9(1):332. doi: 10.1038/s41420-023-01631-7. Cell Death Discov. 2023. PMID: 37666811 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
